{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:46:35Z","timestamp":1793691995292,"version":"4.5.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pupt.2025.102347","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T04:25:28Z","timestamp":1740457528000},"page":"102347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Bispecific domain antibody attenuates airway hyperresponsiveness and pulmonary inflammation in ovalbumin-lipopolysaccharide induced asthma model by inhibiting IL-23 and TNF-\u03b1"],"prefix":"10.1016","volume":"88","author":[{"given":"Chirag Ketan","family":"Gala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sandeep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay H.","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Sunder","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2025.102347_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-024-01834-9","article-title":"A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice","author":"Jin","year":"2024","journal-title":"Nat. Immunol."},{"issue":"50","key":"10.1016\/j.pupt.2025.102347_bib2","first-page":"847","article-title":"Severe asthma: definition, diagnosis and treatment","volume":"111","author":"Lommatzsch","year":"2014","journal-title":"Deutsches Arzteblatt International"},{"issue":"3","key":"10.1016\/j.pupt.2025.102347_bib3","first-page":"776","article-title":"Inhaled corticosteroids safety and adverse effects in patients with asthma","volume":"6","author":"Heffler","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.pupt.2025.102347_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13223-020-00472-8","article-title":"Treatment strategies for asthma: reshaping the concept of asthma management","volume":"16","author":"Papi","year":"2020","journal-title":"Allergy Asthma Clin. Immunol. : Official Journal of the Canadian Society of Allergy and Clinical Immunology"},{"issue":"12","key":"10.1016\/j.pupt.2025.102347_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100726","article-title":"Systemic corticosteroids in asthma: a call to action from world allergy organization and respiratory effectiveness group","volume":"15","author":"Bleecker","year":"2022","journal-title":"The World Allergy Organization Journal"},{"issue":"1","key":"10.1016\/j.pupt.2025.102347_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97236-0","article-title":"Preclinical development of a bispecific TNF\u03b1\/IL-23 neutralising domain antibody as a novel oral treatment for inflammatory bowel disease","volume":"11","author":"Roberts","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pupt.2025.102347_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molimm.2023.02.005","article-title":"Polyspecificity - an emerging trend in the development of clinical antibodies","volume":"155","author":"Sandeep","year":"2023","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.pupt.2025.102347_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000336418","article-title":"Serum IL-23 strongly and inversely correlates with FEV1 in asthmatic children","volume":"159","author":"Ciprandi","year":"2012","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.pupt.2025.102347_bib9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.aller.2017.07.003","article-title":"Comparing the effects of fluticasone, anti-IgE and anti-TNF treatments in a chronic asthma model","volume":"46","author":"Ozkars","year":"2018","journal-title":"Allergol. Immunopathol."},{"issue":"12","key":"10.1016\/j.pupt.2025.102347_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003879","article-title":"Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice","volume":"3","author":"Lewkowich","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2025.102347_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cyto.2015.12.001","article-title":"TNF-\u03b1 enhance Th2 and Th17 immune responses regulating by IL23 during sensitization in asthma model","volume":"79","author":"Lee","year":"2016","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.pupt.2025.102347_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00109-019-01768-y","article-title":"Critical role of interleukin-23 in development of asthma promoted by cigarette smoke","volume":"97","author":"Lee","year":"2019","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"18","key":"10.1016\/j.pupt.2025.102347_bib13","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMoa2030880","article-title":"Risankizumab in severe asthma - a phase 2a, placebo-controlled trial","volume":"385","author":"Brightling","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.pupt.2025.102347_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2222.2005.02407.x","article-title":"Anti-tumor necrosis factor-alpha antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust","volume":"36","author":"Kim","year":"2006","journal-title":"Clin. Exp. Allergy : journal of the British Society for Allergy and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.pupt.2025.102347_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1476-5381.2008.00045.x","article-title":"Etanercept prevents airway hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged Guinea pigs","volume":"156","author":"Nie","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pupt.2025.102347_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00210-017-1459-z","article-title":"Modulation of the IL-23\/IL-17 axis by fenofibrate ameliorates the ovalbumin\/lipopolysaccharide-induced airway inflammation and bronchial asthma in rats","volume":"391","author":"Elaidy","year":"2018","journal-title":"N. Schmied. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.pupt.2025.102347_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00109-023-02393-6","article-title":"IL-23 contributes to Particulate Matter induced allergic asthma in the early life of mice and promotes asthma susceptibility","volume":"102","author":"Park","year":"2024","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"1","key":"10.1016\/j.pupt.2025.102347_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/cr.2009.128","article-title":"IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation","volume":"20","author":"Peng","year":"2010","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.pupt.2025.102347_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00441-021-03538-0","article-title":"Allergic airway inflammation induces upregulation of the expression of IL-23R by macrophages and not in CD3 + T cells and CD11c+F4\/80- dendritic cells of the lung","volume":"389","author":"Leitner","year":"2022","journal-title":"Cell Tissue Res."},{"issue":"4","key":"10.1016\/j.pupt.2025.102347_bib20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/imm.13743","article-title":"Engineered polyspecific antibodies: a new frontier in the field of immunotherapeutics","volume":"171","author":"Sandeep","year":"2024","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.pupt.2025.102347_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/02770903.2016.1223687","article-title":"Lipopolysaccharides promote a shift from Th2-derived airway eosinophilic inflammation to Th17-derived neutrophilic inflammation in an ovalbumin-sensitized murine asthma model","volume":"54","author":"Zhao","year":"2017","journal-title":"J. Asthma : Official Journal of the Association for the Care of Asthma"},{"issue":"11","key":"10.1016\/j.pupt.2025.102347_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02864","article-title":"An experimental model of asthma in rats using ovalbumin and lipopolysaccharide allergens","volume":"5","author":"Thakur","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.pupt.2025.102347_bib23","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2147\/JAA.S298613","article-title":"Embelin alleviates severe airway inflammation in OVA-LPS-induced rat model of allergic asthma","volume":"14","author":"Azman","year":"2021","journal-title":"J. Asthma Allergy"},{"issue":"1","key":"10.1016\/j.pupt.2025.102347_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-022-03337-3","article-title":"Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4\/NF-kB signaling pathway","volume":"20","author":"Wu","year":"2022","journal-title":"J. Transl. Med."},{"issue":"22","key":"10.1016\/j.pupt.2025.102347_bib25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.21037\/atm-20-7114","article-title":"Glutathione ethyl ester supplementation prevents airway hyper-responsiveness in mice","volume":"8","author":"Wang","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"3","key":"10.1016\/j.pupt.2025.102347_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pupt.2008.11.011","article-title":"Amelioration of pulmonary dysfunction and neutrophilic inflammation by PPAR gamma agonist in LPS-exposed Guinea pigs","volume":"22","author":"Sharma","year":"2009","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.pupt.2025.102347_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176017","article-title":"Alpha-1 antitrypsin protects against phosgene-induced acute lung injury by activating the ID1-dependent anti-inflammatory response","volume":"957","author":"He","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.pupt.2025.102347_bib28","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s00210-021-02117-y","article-title":"Tyrosol improves ovalbumin (OVA)-induced asthma in rat model through prevention of airway inflammation","volume":"394","author":"Cellat","year":"2021","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.pupt.2025.102347_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109480","article-title":"Bifidobacterium breve Bif11 supplementation improves depression-related neurobehavioural and neuroinflammatory changes in the mouse","volume":"229","author":"Sushma","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pupt.2025.102347_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105691","article-title":"Supplementation of probiotic Bifidobacterium breve Bif11 reverses neurobehavioural deficits, inflammatory changes and oxidative stress in Parkinson's disease model","volume":"174","author":"Valvaikar","year":"2024","journal-title":"Neurochem. Int."},{"issue":"14","key":"10.1016\/j.pupt.2025.102347_bib31","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.18632\/aging.204874","article-title":"S14G-Humanin ameliorates ovalbumin-induced airway inflammation in asthma mediated by inhibition of toll-like receptor 4 (TLR4) expression and the nuclear factor \u03ba-B (NF-\u03baB)\/early growth response protein-1 (Egr-1) pathway","volume":"15","author":"Su","year":"2023","journal-title":"Aging"},{"issue":"11","key":"10.1016\/j.pupt.2025.102347_bib32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.1440-1681.2006.04481.x","article-title":"Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy","volume":"33","author":"Sharma","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"7","key":"10.1016\/j.pupt.2025.102347_bib33","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/ajrccm.164.7.2010085","article-title":"Eosinophil peroxidase mediates protein nitration in allergic airway inflammation in mice","volume":"164","author":"Duguet","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2025.102347_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174861","article-title":"Intervention of 3-aminobenzamide against Dextran Sulphate Sodium induced colitis in mice: investigations on molecular mechanisms","volume":"920","author":"Singla","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.pupt.2025.102347_bib35","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1021\/acschemneuro.2c00403","article-title":"Neuroprotective potential of HC070, a potent TRPC5 channel inhibitor in Parkinson's disease models: a behavioral and mechanistic study","volume":"13","author":"Vaidya","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"10","key":"10.1016\/j.pupt.2025.102347_bib36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/CM9.0000000000001990","article-title":"Characteristics, phenotypes, mechanisms and management of severe asthma","volume":"135","author":"Chung","year":"2022","journal-title":"Chin. Med J"},{"issue":"4","key":"10.1016\/j.pupt.2025.102347_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12946","article-title":"The TNF\/IL-23\/IL-17 axis-Head-to-head trials comparing different biologics in psoriasis treatment","volume":"92","author":"Ten Bergen","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.pupt.2025.102347_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.672515","article-title":"From bed to bench and back: TNF-\u03b1, IL-23\/IL-17a, and JAK-dependent inflammation in the pathogenesis of psoriatic synovitis","volume":"12","author":"Silvagni","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.pupt.2025.102347_bib39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.coi.2013.08.002","article-title":"Th17-mediated inflammation in asthma","volume":"25","author":"Newcomb","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.pupt.2025.102347_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.960279","article-title":"Dexamethasone-associated metabolic effects in male mice are partially caused by depletion of endogenous corticosterone","volume":"13","author":"Koorneef","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.pupt.2025.102347_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/antiox11010004","article-title":"Dexamethasone administration in mice leads to less body weight gain over time, lower serum glucose, and higher insulin levels independently of NRF2","volume":"11","author":"Filippopoulou","year":"2021","journal-title":"Antioxidants"}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553925000045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553925000045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T15:37:40Z","timestamp":1741275460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553925000045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":41,"alternative-id":["S1094553925000045"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2025.102347","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bispecific domain antibody attenuates airway hyperresponsiveness and pulmonary inflammation in ovalbumin-lipopolysaccharide induced asthma model by inhibiting IL-23 and TNF-\u03b1","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2025.102347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102347"}}